During the past decade, Klinika Kardiologie IKEM conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinika Kardiologie IKEM" #1 collaborator was "University Medical Center Goettingen" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Klinika Kardiologie IKEM" are "Acute Decompensation of Chronic Heart Failure" (1 trials), "Acute Heart Failure" (1 trials), "Mitral Valve Insufficiency" (1 trials) and "New Onset of Heart Failure" (1 trials). Many other conditions were trialed in "Klinika Kardiologie IKEM" in a lesser frequency.

Most popular intervention types in "Klinika Kardiologie IKEM" are "Device" (1 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "MitraClip" (1 trials), "placebo" (1 trials), "standard of care" (1 trials) and "tezosentan" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinika Kardiologie IKEM" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Klinika Kardiologie IKEM". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Klinika Kardiologie IKEM, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Klinika Kardiologie IKEM, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".